Financial results - OPHTAMAX CLINIC S.R.L.

Financial Summary - Ophtamax Clinic S.r.l.
Unique identification code: 37774175
Registration number: J29/345/2023
Nace: 8622
Sales - Ron
467.356
Net Profit - Ron
45.808
Employee
11
The most important financial indicators for the company Ophtamax Clinic S.r.l. - Unique Identification Number 37774175: sales in 2023 was 467.356 euro, registering a net profit of 45.808 euro and having an average number of 11 employees. Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala specializata having the NACE code 8622.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Ophtamax Clinic S.r.l.

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR - - - 322.499 556.695 795.267 494.565 834.613 894.878 467.356
Total Income - EUR - - - 322.499 557.717 797.927 501.235 836.108 895.038 467.356
Total Expenses - EUR - - - 88.807 323.612 460.474 350.939 494.766 653.714 417.630
Gross Profit/Loss - EUR - - - 233.692 234.105 337.453 150.296 341.342 241.324 49.725
Net Profit/Loss - EUR - - - 230.444 228.787 330.405 146.247 334.236 233.395 45.808
Employees - - - 3 5 8 8 11 13 11
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales decreased by -47.6%, from 894.878 euro in the year 2022, to 467.356 euro in 2023. The Net Profit decreased by -186.879 euro, from 233.395 euro in 2022, to 45.808 in the last year.

Check the financial reports for the company - Ophtamax Clinic S.r.l.

Rating financiar

Financial Rating -
Ophtamax Clinic S.r.l.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Ophtamax Clinic S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Ophtamax Clinic S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Ophtamax Clinic S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Ophtamax Clinic S.r.l. - CUI 37774175

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets - - - 15.146 78.328 70.507 72.125 130.053 228.533 213.255
Current Assets - - - 227.005 166.649 272.361 124.543 233.126 178.654 73.798
Inventories - - - 2.527 9.415 3.278 1.148 7.335 3.930 3.505
Receivables - - - 331 45.630 164 834 15.079 34.894 32.485
Cash - - - 224.147 111.604 268.919 122.561 210.712 139.829 37.808
Shareholders Funds - - - 230.487 228.839 330.455 181.008 336.925 233.443 151.691
Social Capital - - - 44 43 42 41 40 41 40
Debts - - - 12.141 16.583 12.705 17.529 28.811 175.342 137.742
Income in Advance - - - 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 73.798 euro in 2023 which includes Inventories of 3.505 euro, Receivables of 32.485 euro and cash availability of 37.808 euro.
The company's Equity was valued at 151.691 euro, while total Liabilities amounted to 137.742 euro. Equity decreased by -81.045 euro, from 233.443 euro in 2022, to 151.691 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Ophtamax Clinic S.r.l.

Comments - Ophtamax Clinic S.r.l.

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.